|
|
| Clinical Research As A Delicate Ecosystem | Making the right outsourcing decision can significantly contribute to the success and growth of your program, providing essential support and resources that empower it to thrive in its objectives and endeavors. Entrust that your program is in hands you can rely on, where integrity is paramount, and excellence is the standard. |
|
|
|
|
A conversation with Erich H. Bozenhardt, United Therapeutics | The ISPE sought to accelerate guideline development for allogeneic cell therapy. This discussion digs into some of the bigger themes in its recent guide. |
|
|
|
|
| Faster From Formulation To Fill/Finish | Article | By Andrew Besherwor, Singota Solutions | Optimize your speed to clinic by securing a development and aseptic fill/finish partner to support your applications with the right manufacturing equipment, communications, and SOPs. |
|
|
| My Worst Nightmare In RSTM: Accidental Unblinding | Article | By Sheri Lillis, Medidata, a Dassault Systemes company | Learn how collaborative efforts from study managers, supply managers, biostatisticians, designers, and clinicians can better protect the blind in clinical trials and prevent accidental unblinding. |
|
|
|
|
| Proactive Strategies To Evaluate And Mitigate Clinical Supply Risk | Successful clinical trials are crucial for advancing a novel therapeutic to market and maintaining a competitive edge. Clinical trials face risks such as supply shortages which can cause costly delays and impact the safety and well-being of the patients involved in the trial. Learn about strategies that can help build an understanding of risk assessment when developing a clinical supply plan with this on demand webinar. |
|
|
|
|
|
.png){kind=logo}
